Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Biomarker Modulation Study of Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer

NCT02278965 is registered in ClinicalTrials.gov with Katherine D. Crew as lead sponsor.

NCT NCT02278965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02278965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Biomarker Modulation Study of Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Lead sponsor
Katherine D. Crew
Phase
Phase 1
Overall status
Completed
Start date
January 22, 2015
Completion date
April 19, 2017
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, stage 0 breast carcinoma, stage i breast carcinoma, stage ii breast carcinoma, stage iii breast carcinoma